Are any weight loss drugs covered by insurance?

GLP-1 medications can run over $1,000 a month without coverage, a price tag that discourages many people from considering them. If you’re wondering whether any weight loss drugs are covered by insurance, the short answer is yes, but eligibility depends on your plan type and a handful of clinical factors. Let’s explore a few factors you should consider before deciding on a treatment.

What are GLP-1 weight loss medications?

GLP-1 medications are a class of prescription drugs that mimic a natural hormone, glucagon-like peptide-1. The medicine affects your system in many ways, but the main two factors that drive weight loss are hunger and blood sugar regulation. 

Four name-brand medications are FDA-approved specifically for weight loss: Wegovy® (semaglutide), Zepbound® (tirzepatide), Saxenda® (liraglutide), and Foundayo® (orforglipron). You’ve likely also heard of Ozempic® and Mounjaro®, which contain the same active ingredients as Wegovy® and Zepbound® respectively, but they’re only FDA-approved to treat type 2 diabetes.

Are weight loss medications covered by insurance?

It depends. Because insurers usually follow FDA indications when setting coverage rules, navigating your plan’s GLP-1 treatment coverage is often confusing. A brand approved for diabetes may be covered, while its weight loss-approved counterpart isn’t—even when they share the same active ingredient. This can make your coverage difficult to untangle.

Whether GLP-1s are covered by insurance comes down almost entirely to the type of plan you have. Employer plans, Medicare, Medicaid, and Affordable Care Act (ACA) marketplace plans all handle coverage differently, and none of them guarantees it. 

The coverage landscape is shifting

Some programs are expanding access to GLP-1s. Medicare, for example, now covers GLP-1 treatment for weight loss under a short-term program called the “Medicare GLP-1 Bridge.” And in January 2025, North Dakota became the first state to add GLP-1s to its essential health benefits benchmark plan. 

However, other providers are scaling down. For instance, Medicaid has moved in the opposite direction: Only 13 states cover GLP-1s for obesity treatment as of early 2026, down from 16 in late 2025. States cited rising costs as the reason for pulling back.

Pricing is the core reason coverage is so inconsistent. At $1,000 a month or more, GLP-1s are becoming one of the fastest-growing line items in employer pharmacy budgets. Not every company is willing or able to cover this expense, making out-of-pocket costs unpredictable. The only reliable way to know what you’d pay is talking to your insurance provider.

Coverage by plan type: A quick overview

Here’s how each plan type typically handles GLP-1s for weight loss.

Employer insurance

For most working-age adults, employer-sponsored plans are the most realistic path to GLP-1 treatment coverage. But even if your company’s plan includes it, there may be conditions. Plans often require you to have a qualifying BMI to access the medication.

Medicare

Medicare has historically excluded weight loss drugs, but that’s changing in 2026. Eligibility for the new program hinges on your BMI and whether you have a related condition like prediabetes, heart disease, or high blood pressure. Ask your providers to check whether you meet the criteria.

Medicaid

Medicaid coverage is defined state by state. Currently, and only a limited number of states cover these medications for obesity treatment. To learn more about coverage, call your provider.

Marketplace and private insurance

Only 26 out of 300 ACA marketplace plans covered GLP-1s for obesity in 2026, and that number has been shrinking. If you’re shopping for a plan or already enrolled, pull your Summary of Benefits and Coverage (SBC) document to see whether GLP-1 treatment is included. Every plan is required to provide one.

What to expect and how to prepare before requesting coverage

Most insurance plans use a similar set of criteria to approve GLP-1s. Knowing how to get insurance to cover weight loss medication often comes down to arriving prepared. Here’s what you’ll need:

• A qualifying BMI: Most plans require a BMI of 30 or higher. Or, you might qualify with a BMI of 27 and a weight-related condition like high blood pressure, prediabetes, or high cholesterol. These thresholds mirror the FDA’s own approval criteria for Wegovy® and Zepbound®. Your doctor can document this during a visit.
• A confirmed diagnosis: Your prescription needs to be written for an FDA-approved use with the correct diagnosis code. Insurers follow FDA indications closely, and a mismatch between the code and the drug can hold up requests. Off-label prescriptions might not be covered.
• Prior authorization: Your provider’s office handles this submission on your behalf, but incomplete documentation is a common cause of delays. Make sure your clinical notes, BMI records, and any supporting paperwork are current before they send anything.
• Evidence of past weight loss attempts: Some plans require proof of previous diet and exercise attempts before approving GLP-1s. Notes from previous appointments or records from a prior program can support the request.
• Your insurance card and plan documents: Check your drug formulary and your SBC before starting the process. Knowing early if they outright exclude GLP-1s saves time. 

What if insurance doesn’t cover treatment?

A denial or gap in coverage isn’t the end of the road — there are more affordable options available. 

Wegovy®’s manufacturer, Novo Nordisk, runs a savings program called NovoCare. New patients can access Wegovy® starting at $199 a month. Eli Lilly, Zepbound®’s manufacturer, offers a similar deal. Their LillyDirect self-pay option brings costs down to $299 to $499 a month, depending on the dose. Note that neither plan is available to people on Medicare, Medicaid, or other government-funded plans.

Even if you’re paying out of pocket, you have some low-cost options to choose from. An oral Wegovy tablet launched in January 2026 with cash pricing starting at $149 a month. Also, a generic version of Saxenda® reached pharmacies in August 2025, and it’s 14% cheaper than Zepbound®.

When to talk to a doctor

A clinician can do more than write a prescription: They can confirm whether you meet the clinical criteria, manage the prior authorization process, and map out alternatives if your insurer says no. Getting that conversation on the calendar early puts you ahead of most of the paperwork.

If you’re navigating what insurance covers GLP-1 for weight loss, talk to Maven Clinic’s healthcare team. Our experts can walk you through your options and help you make sense of your coverage.

FAQ

Can I get GLP-1s covered if I only want to lose a small amount of weight?

Coverage usually depends on BMI thresholds rather than weight loss goals. To qualify, you often need a BMI of 30 or higher, or 27 with a related health condition. Talk to your doctor about eligibility and other weight-loss strategies. 

Does insurance cover GLP-1 medications differently for women than for men?

From a BMI standpoint, no — the thresholds are the same. But women might have additional health conditions that insurance would cover GLP-1 treatment for, like PCOS or perimenopause. 

How long does it typically take to get prior authorization approved?

Each provider is different, but approval can take anywhere from a few days to a few weeks. Double-checking your paperwork before turning it in is the best way to speed up the process. 

Can a telehealth provider help me get coverage for GLP-1s?

Yes, a telehealth provider can prescribe GLP-1 treatment. This can be a much more accessible option, particularly for those without access to specialized doctors.

‍